Detalles de la búsqueda
1.
Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records.
Comput Biol Med
; 168: 107757, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38039893
2.
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial.
BMJ Open
; 12(9): e061339, 2022 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130755
3.
Response to "Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation".
Kidney Int Rep
; 8(2): 378, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36815117
4.
Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis.
Biologics
; 17: 11-14, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36721867
5.
The impact of reclassification by the 2022 ACR/EULAR classification criteria on risk factors for relapse in patients with ANCA-associated vasculitis.
Clin Kidney J
; 16(12): 2754-2756, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38045999
6.
Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Kidney Int Rep
; 7(3): 624-628, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257076
Resultados
1 -
6
de 6
1
Próxima >
>>